Adhera Therapeutics Statistics
Total Valuation
ATRX has a market cap or net worth of $54,085. The enterprise value is $10.85 million.
| Market Cap | 54,085 |
| Enterprise Value | 10.85M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ATRX has 7.22 million shares outstanding. The number of shares has increased by 36.16% in one year.
| Shares Outstanding | 7.22M |
| Shares Change (YoY) | +36.16% |
| Shares Change (QoQ) | -95.63% |
| Owned by Insiders (%) | 11.67% |
| Owned by Institutions (%) | n/a |
| Float | 6.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
| Current Ratio | 0.00 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.06 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -5,737.66% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.26M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATRX has paid $211,753 in taxes.
| Income Tax | 211,753 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.74% in the last 52 weeks. The beta is -0.10, so ATRX's price volatility has been lower than the market average.
| Beta (1Y) | -0.10 |
| 52-Week Price Change | -97.74% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 42.88 |
| Average Volume (30 Days) | 108,079 |
Short Selling Information
The latest short interest is 2,046, so 0.03% of the outstanding shares have been sold short.
| Short Interest | 2,046 |
| Short Previous Month | 1,986 |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 3.24 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.28M |
| Pretax Income | -4.13M |
| Net Income | -2.53M |
| EBITDA | -1.74M |
| EBIT | -3.38M |
| Earnings Per Share (EPS) | -$0.60 |
Balance Sheet
The company has $32,388 in cash and $10.83 million in debt, giving a net cash position of -$10.80 million or -$1.50 per share.
| Cash & Cash Equivalents | 32,388 |
| Total Debt | 10.83M |
| Net Cash | -10.80M |
| Net Cash Per Share | -$1.50 |
| Equity / Book Value | -26.32M |
| Book Value Per Share | -3.64 |
| Working Capital | -26.32M |
Cash Flow
| Operating Cash Flow | -808,155 |
| Capital Expenditures | n/a |
| Free Cash Flow | -808,155 |
| FCF Per Share | -$0.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.16% |
| Shareholder Yield | -36.16% |
| Earnings Yield | -4,675.63% |
| FCF Yield | -1,494.23% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 6, 2022. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 6, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |